Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cetrorelix Pamoate in Symptomatic BPH
NCT00449150Phase 3Terminated
- Sponsor
- COSCIENS Biopharma Inc.
- Start
- Mar 2007
- Primary completion
- Jun 2009
- Modality
- Peptides, Small Molecules
- Countries
- 4
01
Overview
A Phase 3 trial of cetrorelix in benign prostatic hyperplasia (BPH), sponsored by COSCIENS Biopharma Inc.. Started Mar 2007; status: terminated.
02
Drugs
cetrorelix
03
Conditions
benign prostatic hyperplasia (BPH)
Beyond the preview
Go deeper on NCT00449150.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00449150.